No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / analysis*
-
Biopsy
-
Capecitabine
-
Carcinoma / chemistry
-
Carcinoma / drug therapy*
-
Carcinoma / secondary
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Fluorouracil / administration & dosage
-
Fluorouracil / analogs & derivatives
-
Head and Neck Neoplasms / chemistry
-
Head and Neck Neoplasms / drug therapy*
-
Head and Neck Neoplasms / pathology
-
Humans
-
Immunohistochemistry
-
Lapatinib
-
Liver Neoplasms / chemistry
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary
-
Male
-
Middle Aged
-
Quinazolines / administration & dosage
-
Receptor, ErbB-2 / analysis*
-
Scalp / chemistry
-
Scalp / drug effects*
-
Scalp / pathology
-
Skin Neoplasms / chemistry
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology
-
Time Factors
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Biomarkers, Tumor
-
Quinazolines
-
Lapatinib
-
Deoxycytidine
-
Capecitabine
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Fluorouracil